We engage with the public, academia, and the private sector to foster a broader understanding of AI and emerging technology policy issues.

To address the gap between academic and commercial incentives, the U.S. government should fund centralized research programs, known as FROs, to address well-defined challenges.

The U.S. bioeconomy is growing rapidly, innovation is needed to sustain and maintain this growth. Shaping policy to consider workforce development, advanced agriculture, bioindustrial and biotech sectors will be imperative to keep the needle moving forward.

We aim to catalyze a more nimble science funding ecosystem, capable of keeping up with and facilitating new innovations to improve the lives of people around the world.